| Dr Kelly R Glenn, DO | |
|
1906 Blake Ave, Glenwood Springs, CO 81601-4227 | |
| (970) 384-6730 | |
| Not Available |
| Full Name | Dr Kelly R Glenn |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 18 Years |
| Location | 1906 Blake Ave, Glenwood Springs, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710193776 | NPI | - | NPPES |
| 07987846 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 49141 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Valley View Hospital Association | Glenwood springs, CO | Hospital |
| Decatur Morgan Hospital - Decatur Campus | Decatur, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Decatur Morgan Emergency Medicine | 0446680862 | 21 |
News Archive
Two key, independent proof-of-concept studies conducted for NellOne Therapeutics, Inc. demonstrate the potential efficacy of the company's lead therapeutic candidate for both skeletal muscle wound healing and myocardial infarction.
The Alzheimer's Drug Discovery Foundation and The Association for Frontotemporal Degeneration invite scientists from academia and the biotechnology industry worldwide to apply for research grants to develop Frontotemporal Dementia (FTD)-specific biomarkers that reflect pathological and clinical differences so that appropriate patients can be selected for clinical trials and responses to investigational treatments can be monitored.
For decades most cancers have been treated with a core standard of treatments that include surgery, radiation, and chemotherapy. Now, immunotherapy—a type of treatment that harnesses the patient's immune system to combat the disease—represents the future of cancer treatment, with its efficacy being demonstrated in even the most aggressive types of cancer.
Investigators at Nationwide Children's Hospital and Cincinnati Children's Hospital Medical Center are hoping to better identify adolescents at risk for suicide and improve how these at-risk children receive follow up mental health treatment.
› Verified 3 days ago
| Entity Name | Island Medical Alabama Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104097666 PECOS PAC ID: 3072682103 Enrollment ID: O20080515000492 |
News Archive
Two key, independent proof-of-concept studies conducted for NellOne Therapeutics, Inc. demonstrate the potential efficacy of the company's lead therapeutic candidate for both skeletal muscle wound healing and myocardial infarction.
The Alzheimer's Drug Discovery Foundation and The Association for Frontotemporal Degeneration invite scientists from academia and the biotechnology industry worldwide to apply for research grants to develop Frontotemporal Dementia (FTD)-specific biomarkers that reflect pathological and clinical differences so that appropriate patients can be selected for clinical trials and responses to investigational treatments can be monitored.
For decades most cancers have been treated with a core standard of treatments that include surgery, radiation, and chemotherapy. Now, immunotherapy—a type of treatment that harnesses the patient's immune system to combat the disease—represents the future of cancer treatment, with its efficacy being demonstrated in even the most aggressive types of cancer.
Investigators at Nationwide Children's Hospital and Cincinnati Children's Hospital Medical Center are hoping to better identify adolescents at risk for suicide and improve how these at-risk children receive follow up mental health treatment.
› Verified 3 days ago
| Entity Name | Alteon Health Alabama, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477708857 PECOS PAC ID: 5698830552 Enrollment ID: O20090210000557 |
News Archive
Two key, independent proof-of-concept studies conducted for NellOne Therapeutics, Inc. demonstrate the potential efficacy of the company's lead therapeutic candidate for both skeletal muscle wound healing and myocardial infarction.
The Alzheimer's Drug Discovery Foundation and The Association for Frontotemporal Degeneration invite scientists from academia and the biotechnology industry worldwide to apply for research grants to develop Frontotemporal Dementia (FTD)-specific biomarkers that reflect pathological and clinical differences so that appropriate patients can be selected for clinical trials and responses to investigational treatments can be monitored.
For decades most cancers have been treated with a core standard of treatments that include surgery, radiation, and chemotherapy. Now, immunotherapy—a type of treatment that harnesses the patient's immune system to combat the disease—represents the future of cancer treatment, with its efficacy being demonstrated in even the most aggressive types of cancer.
Investigators at Nationwide Children's Hospital and Cincinnati Children's Hospital Medical Center are hoping to better identify adolescents at risk for suicide and improve how these at-risk children receive follow up mental health treatment.
› Verified 3 days ago
| Entity Name | Island Medical Coosa Valley, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083948558 PECOS PAC ID: 1658413778 Enrollment ID: O20100127000486 |
News Archive
Two key, independent proof-of-concept studies conducted for NellOne Therapeutics, Inc. demonstrate the potential efficacy of the company's lead therapeutic candidate for both skeletal muscle wound healing and myocardial infarction.
The Alzheimer's Drug Discovery Foundation and The Association for Frontotemporal Degeneration invite scientists from academia and the biotechnology industry worldwide to apply for research grants to develop Frontotemporal Dementia (FTD)-specific biomarkers that reflect pathological and clinical differences so that appropriate patients can be selected for clinical trials and responses to investigational treatments can be monitored.
For decades most cancers have been treated with a core standard of treatments that include surgery, radiation, and chemotherapy. Now, immunotherapy—a type of treatment that harnesses the patient's immune system to combat the disease—represents the future of cancer treatment, with its efficacy being demonstrated in even the most aggressive types of cancer.
Investigators at Nationwide Children's Hospital and Cincinnati Children's Hospital Medical Center are hoping to better identify adolescents at risk for suicide and improve how these at-risk children receive follow up mental health treatment.
› Verified 3 days ago
| Entity Name | Alabama Emergency Physician Partners, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891031894 PECOS PAC ID: 4082868641 Enrollment ID: O20130206000466 |
News Archive
Two key, independent proof-of-concept studies conducted for NellOne Therapeutics, Inc. demonstrate the potential efficacy of the company's lead therapeutic candidate for both skeletal muscle wound healing and myocardial infarction.
The Alzheimer's Drug Discovery Foundation and The Association for Frontotemporal Degeneration invite scientists from academia and the biotechnology industry worldwide to apply for research grants to develop Frontotemporal Dementia (FTD)-specific biomarkers that reflect pathological and clinical differences so that appropriate patients can be selected for clinical trials and responses to investigational treatments can be monitored.
For decades most cancers have been treated with a core standard of treatments that include surgery, radiation, and chemotherapy. Now, immunotherapy—a type of treatment that harnesses the patient's immune system to combat the disease—represents the future of cancer treatment, with its efficacy being demonstrated in even the most aggressive types of cancer.
Investigators at Nationwide Children's Hospital and Cincinnati Children's Hospital Medical Center are hoping to better identify adolescents at risk for suicide and improve how these at-risk children receive follow up mental health treatment.
› Verified 3 days ago
| Entity Name | Nes Tennessee, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437606605 PECOS PAC ID: 3678472040 Enrollment ID: O20161031002328 |
News Archive
Two key, independent proof-of-concept studies conducted for NellOne Therapeutics, Inc. demonstrate the potential efficacy of the company's lead therapeutic candidate for both skeletal muscle wound healing and myocardial infarction.
The Alzheimer's Drug Discovery Foundation and The Association for Frontotemporal Degeneration invite scientists from academia and the biotechnology industry worldwide to apply for research grants to develop Frontotemporal Dementia (FTD)-specific biomarkers that reflect pathological and clinical differences so that appropriate patients can be selected for clinical trials and responses to investigational treatments can be monitored.
For decades most cancers have been treated with a core standard of treatments that include surgery, radiation, and chemotherapy. Now, immunotherapy—a type of treatment that harnesses the patient's immune system to combat the disease—represents the future of cancer treatment, with its efficacy being demonstrated in even the most aggressive types of cancer.
Investigators at Nationwide Children's Hospital and Cincinnati Children's Hospital Medical Center are hoping to better identify adolescents at risk for suicide and improve how these at-risk children receive follow up mental health treatment.
› Verified 3 days ago
| Entity Name | Decatur Morgan Emergency Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316571615 PECOS PAC ID: 0446680862 Enrollment ID: O20200424001929 |
News Archive
Two key, independent proof-of-concept studies conducted for NellOne Therapeutics, Inc. demonstrate the potential efficacy of the company's lead therapeutic candidate for both skeletal muscle wound healing and myocardial infarction.
The Alzheimer's Drug Discovery Foundation and The Association for Frontotemporal Degeneration invite scientists from academia and the biotechnology industry worldwide to apply for research grants to develop Frontotemporal Dementia (FTD)-specific biomarkers that reflect pathological and clinical differences so that appropriate patients can be selected for clinical trials and responses to investigational treatments can be monitored.
For decades most cancers have been treated with a core standard of treatments that include surgery, radiation, and chemotherapy. Now, immunotherapy—a type of treatment that harnesses the patient's immune system to combat the disease—represents the future of cancer treatment, with its efficacy being demonstrated in even the most aggressive types of cancer.
Investigators at Nationwide Children's Hospital and Cincinnati Children's Hospital Medical Center are hoping to better identify adolescents at risk for suicide and improve how these at-risk children receive follow up mental health treatment.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kelly R Glenn, DO 1906 Blake Ave, Glenwood Springs, CO 81601-4227 Ph: (970) 384-6730 | Dr Kelly R Glenn, DO 1906 Blake Ave, Glenwood Springs, CO 81601-4227 Ph: (970) 384-6730 |
News Archive
Two key, independent proof-of-concept studies conducted for NellOne Therapeutics, Inc. demonstrate the potential efficacy of the company's lead therapeutic candidate for both skeletal muscle wound healing and myocardial infarction.
The Alzheimer's Drug Discovery Foundation and The Association for Frontotemporal Degeneration invite scientists from academia and the biotechnology industry worldwide to apply for research grants to develop Frontotemporal Dementia (FTD)-specific biomarkers that reflect pathological and clinical differences so that appropriate patients can be selected for clinical trials and responses to investigational treatments can be monitored.
For decades most cancers have been treated with a core standard of treatments that include surgery, radiation, and chemotherapy. Now, immunotherapy—a type of treatment that harnesses the patient's immune system to combat the disease—represents the future of cancer treatment, with its efficacy being demonstrated in even the most aggressive types of cancer.
Investigators at Nationwide Children's Hospital and Cincinnati Children's Hospital Medical Center are hoping to better identify adolescents at risk for suicide and improve how these at-risk children receive follow up mental health treatment.
› Verified 3 days ago
Ms. Brandy Delane Drake, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1906 Blake Ave, Glenwood Springs, CO 81601 Phone: 970-945-6535 | |
Dr. Jeffrey A Wuerker, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1905 Blake Ave, Suite 101, Glenwood Springs, CO 81601 Phone: 970-945-2840 Fax: 970-945-2893 | |
Dr. Travis W Martin, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1906 Blake Ave, Glenwood Springs, CO 81601 Phone: 970-945-6535 Fax: 970-945-5429 | |
Dr. Sandra Lopina Deveny, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1905 Blake Ave, Suite 101, Glenwood Springs, CO 81601 Phone: 970-945-2840 Fax: 970-945-2893 | |
Ben N Peery, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1906 Blake Ave, Glenwood Springs, CO 81601 Phone: 970-945-6535 Fax: 970-384-8173 | |
Dr. Sarah Villafranco, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1906 Blake Ave, Glenwood Springs, CO 81601 Phone: 970-384-7300 |